According to a recent report by market research and consulting firm MarketsandMarkets, the global Biomarkers Market is expected to grow at a CAGR of 18.5% from 2013 to 2018, to reach $40.8 billion by 2018.
A number of factors such as the rising demand for personalized medicine and companion diagnostics have increased the utility of Biomarkers in the healthcare sector.
Omics technology including, proteomics, genomics, transcriptomics, and metabolomics, is the largest segment contributing to the growth of this market.
Biomarkers market worth $40.8 billion by 2018